Insider transactions

Deval L Patrick

CIK 1053466 · last filed 2026-09-17

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$5.68M
Companies
6
Total Filings
69
Lifetime Open-Market Net
-$6.03M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

GBT price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
BAIN CAPITAL, LLC
200 CLARENDON STREET
BOSTON, MA 02116
State of Incorporation
DE
Related Filers
COCA COLA ENTERPRISES INC — 28 joint filings, latest 2004-07-02
TWILIO INC — 23 joint filings, latest 2026-06-17
COCA COLA CO — 1 joint filings, latest 2004-11-23
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TWLO Director 19,055 $211.02 $4.02M $0 23 2026-09-17
TOST Director 45,815 $33.80 $1.55M -$1.12M 14 2026-06-16
Cerevel Therapeutics Holdings, Inc. (CERE) Delisted Director 13,743 $44.96 $617.9K -$2.22M 5 2024-06-07
AMWL Director 8,895 $12.78 $113.7K $150.0K 6 2023-06-26
Global Blood Therapeutics, Inc. (GBT) Delisted Director 0 $68.49 $0 -$2.83M 16 2022-10-06
Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted Director — $18.07 — $0 1 2021-02-03

Recent Filings · Page 4 of 7

69 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-06-05 TOST Exer (M) +11,292 $0 EDGAR
2023-03-17 TWLO Grant (A) +1,101 $0 EDGAR
2023-02-24 TOST Exer (M) +7,640 $0 EDGAR
2022-12-19 TWLO Grant (A) +1,565 $0 EDGAR
2022-10-06 Global Blood Therapeutics, Inc. (GBT) Delisted Disp (D) −9,037 $0 EDGAR
2022-09-19 TWLO Grant (A) +1,008 $0 EDGAR
2022-09-14 Cerevel Therapeutics Holdings, Inc. (CERE) Delisted Mixed — -$866.4K EDGAR
2022-06-17 TWLO Grant (A) +736 $0 EDGAR
2022-06-16 Global Blood Therapeutics, Inc. (GBT) Delisted Mixed +3,600 $0 EDGAR
2022-06-16 Cerevel Therapeutics Holdings, Inc. (CERE) Delisted Grant (A) — $0 EDGAR
Showing 31–40 of 69
Page 4 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.